CRYOPORT, INC. Other Current Liabilities
CRYOPORT, INC. (CYRX) had Other Current Liabilities of $53.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2022-08-04
- 2022-06-30: Other Liabilities, Current $53.00K.
- 2022-03-31: Other Liabilities, Current $53.00K.
- 2021-12-31: Other Liabilities, Current $61.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2022-06-30 | $53.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $53.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $61.00K 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |